Von dem Buch Novel Technologies For Vaccine Development haben wir 2 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
100%: Editor: Igor Lukashevich, Series Editor: Haval Shirwan: Novel Technologies For Vaccine Development (ISBN: 9783709119808) Springer Verlag Gmbh, in Englisch.Nur diese Ausgabe anzeigen…
34%: Igor Lukashevich (Editor), Haval Shirwan (Editor): Novel Technologies for Vaccine Development (Hardback) (ISBN: 9783709118177) in Deutsch, Broschiert.Nur diese Ausgabe anzeigen…
Novel Technologies For Vaccine Development - 14 Angebote vergleichen
| Preise | 2016 | 2017 | 2019 |
|---|---|---|---|
| Schnitt | € 169,00 | € 176,92 | € 132,86 |
| Nachfrage |
1
Novel Technologies for Vaccine Development
DE PB NWISBN: 9783709119808 bzw. 3709119804, in Deutsch, Springer Shop, Taschenbuch, neu.
Lieferung aus: Italien, Lagernd, zzgl. Versandkosten.
This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharmaceutical products and several examples at the advanced pre-clinical or clinical stage are presented. Nevertheless, the most efforts were focused on novel and very innovative technologies for new generation of vector-based vaccines. Furthermore, specific topics such as delivery and adjuvant and protection strategies for cell-mediated-based vaccines are presented. Given its scope, the book is a “must read” for all those involved in vaccine development, both in academia and industrial vaccine development. Soft cover.
This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharmaceutical products and several examples at the advanced pre-clinical or clinical stage are presented. Nevertheless, the most efforts were focused on novel and very innovative technologies for new generation of vector-based vaccines. Furthermore, specific topics such as delivery and adjuvant and protection strategies for cell-mediated-based vaccines are presented. Given its scope, the book is a “must read” for all those involved in vaccine development, both in academia and industrial vaccine development. Soft cover.
2
Novel Technologies for Vaccine Development (2016)
DE PB NWISBN: 9783709119808 bzw. 3709119804, in Deutsch, Springer Verlag Gmbh, Taschenbuch, neu.
Lieferung aus: Niederlande, Vermoedelijk 4-6 weken.
bol.com.
This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharmaceutical products and several examples at the advanced pre-clinical or clinical stage are presented. Nevertheless, the most efforts were focused on novel and very innovative technologies for new gene... This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharmaceutical products and several examples at the advanced pre-clinical or clinical stage are presented. Nevertheless, the most efforts were focused on novel and very innovative technologies for new generation of vector-based vaccines. Furthermore, specific topics such as delivery and adjuvant and protection strategies for cell-mediated-based vaccines are presented. Given its scope, the book is a must readö for all those involved in vaccine development, both in academia and industrial vaccine development.Taal: Engels;Afmetingen: 21x235x155 mm;Gewicht: 611,00 gram;Verschijningsdatum: augustus 2016;ISBN10: 3709119804;ISBN13: 9783709119808; Engelstalig | Paperback | 2016.
bol.com.
This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharmaceutical products and several examples at the advanced pre-clinical or clinical stage are presented. Nevertheless, the most efforts were focused on novel and very innovative technologies for new gene... This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharmaceutical products and several examples at the advanced pre-clinical or clinical stage are presented. Nevertheless, the most efforts were focused on novel and very innovative technologies for new generation of vector-based vaccines. Furthermore, specific topics such as delivery and adjuvant and protection strategies for cell-mediated-based vaccines are presented. Given its scope, the book is a must readö for all those involved in vaccine development, both in academia and industrial vaccine development.Taal: Engels;Afmetingen: 21x235x155 mm;Gewicht: 611,00 gram;Verschijningsdatum: augustus 2016;ISBN10: 3709119804;ISBN13: 9783709119808; Engelstalig | Paperback | 2016.
3
Novel Technologies for Vaccine Development Igor S Lukashevich Editor
~EN PB NWISBN: 9783709119808 bzw. 3709119804, vermutlich in Englisch, Springer Vienna, Taschenbuch, neu.
Lieferung aus: Vereinigte Staaten von Amerika, Lagernd, zzgl. Versandkosten.
This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharmaceutical products and several examples at the advanced pre-clinical or clinical stage are presented. Nevertheless, the most efforts were focused on novel and very innovative technologies for new generation of vector-based vaccines. Furthermore, specific topics such as delivery and adjuvant and protection strategies for cell-mediated-based vaccines are presented. Given its scope, the book is a “must read” for all those involved in vaccine development, both in academia and industrial vaccine development.
This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharmaceutical products and several examples at the advanced pre-clinical or clinical stage are presented. Nevertheless, the most efforts were focused on novel and very innovative technologies for new generation of vector-based vaccines. Furthermore, specific topics such as delivery and adjuvant and protection strategies for cell-mediated-based vaccines are presented. Given its scope, the book is a “must read” for all those involved in vaccine development, both in academia and industrial vaccine development.
4
Novel Technologies For Vaccine Development
~EN NWISBN: 9783709119808 bzw. 3709119804, vermutlich in Englisch, neu.
Lieferung aus: Kanada, Lagernd, zzgl. Versandkosten.
This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharmaceutical products and several examples at the advanced pre-clinical or clinical stage are presented. Nevertheless, the most efforts were focused on novel and very innovative technologies for new generation of vector-based vaccines. Furthermore, specific topics such as delivery and adjuvant and protection strategies for cell-mediated-based vaccines are presented. Given its scope, the book is a "must read" for all those involved in vaccine development, both in academia and industrial vaccine development.
This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharmaceutical products and several examples at the advanced pre-clinical or clinical stage are presented. Nevertheless, the most efforts were focused on novel and very innovative technologies for new generation of vector-based vaccines. Furthermore, specific topics such as delivery and adjuvant and protection strategies for cell-mediated-based vaccines are presented. Given its scope, the book is a "must read" for all those involved in vaccine development, both in academia and industrial vaccine development.
5
Novel Technologies for Vaccine Development (2014)
~EN PB NW RPISBN: 3709119804 bzw. 9783709119808, vermutlich in Englisch, Springer Vienna, Taschenbuch, neu, Nachdruck.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
7
Symbolbild
Novel Technologies for Vaccine Development (2014)
DE HC NWISBN: 9783709118177 bzw. 3709118174, in Deutsch, Springer, gebundenes Buch, neu.
Von Händler/Antiquariat, Book Deals [60506629], Lewiston, NY, U.S.A.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
8
Symbolbild
Novel Technologies for Vaccine Development (2015)
DE NWISBN: 9783709118177 bzw. 3709118174, in Deutsch, Springer-Verlag KG Jan 2015, neu.
Lieferung aus: Deutschland, Versandkostenfrei.
Von Händler/Antiquariat, Rheinberg-Buch [53870650], Bergisch Gladbach, Germany.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Von Händler/Antiquariat, Rheinberg-Buch [53870650], Bergisch Gladbach, Germany.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
9
Novel Technologies for Vaccine Development (2014)
DE NWISBN: 9783709118177 bzw. 3709118174, in Deutsch, Springer-Verlag KG, neu.
Lieferung aus: Deutschland, Versandkostenfrei.
Buchhandlung Kühn GmbH, [4368407].
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Buchhandlung Kühn GmbH, [4368407].
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
10
Novel Technologies for Vaccine Development (2014)
DE NWISBN: 9783709118177 bzw. 3709118174, in Deutsch, Springer-Verlag KG, neu.
buchversandmimpf2000, [3715720].
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…